Literature DB >> 29866894

Mifepristone.

Sheila Dunn1, Melissa Brooks2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29866894      PMCID: PMC5988520          DOI: 10.1503/cmaj.180047

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.

Authors:  Patricio Sanhueza Smith; Melanie Peña; Ilana G Dzuba; María Laura García Martinez; Ana Gabriela Aranguré Peraza; Manuel Bousiéguez; Tara Shochet; Beverly Winikoff
Journal:  Reprod Health Matters       Date:  2015-02

2.  Medical Abortion.

Authors:  Dustin Costescu; Edith Guilbert; Jeanne Bernardin; Amanda Black; Sheila Dunn; Brian Fitzsimmons; Wendy V Norman; Helen Pymar; Judith Soon; Konia Trouton; Marie-Soleil Wagner; Ellen Wiebe; Karen Gold; Marie-Ève Murray; Beverly Winikoff; Matthew Reeves
Journal:  J Obstet Gynaecol Can       Date:  2016-04-23
  2 in total
  3 in total

1.  Abortion services in Canada: access and safety.

Authors:  Laura Schummers; Wendy V Norman
Journal:  CMAJ       Date:  2019-05-13       Impact factor: 8.262

2.  Abortion services and providers in Canada in 2019: results of a national survey.

Authors:  Regina M Renner; Madeleine Ennis; Damien Contandriopoulos; Edith Guilbert; Sheila Dunn; Janusz Kaczorowski; Elizabeth K Darling; Arianne Albert; Claire Styffe; Wendy V Norman
Journal:  CMAJ Open       Date:  2022-09-27

3.  "I just was really scared, because it's already such an uncertain time": Exploring women's abortion experiences during the COVID-19 pandemic in Canada.

Authors:  Srishti Hukku; Andréanne Ménard; Julia Kemzang; Erin Hastings; Angel M Foster
Journal:  Contraception       Date:  2022-02-03       Impact factor: 3.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.